Complete remission in acute myeloid leukaemia after treatment with recombinant human granulocyte colony-stimulating factor and high dose intravenous methylprednisolone.
Sugawara
T
T
Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Sato
A
A
Shishido
T
T
Okuda
M
M
Kameoka
J
J
Meguro
K
K
Endo
K
K
Yoshinaga
K
K
D000208:Acute Disease; D000293:Adolescent; D004334:Drug Administration Schedule; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use; D012074:Remission Induction
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D008775:Methylprednisolone